- Home
- CTSO vs GUTS Comparison
CTSO vs GUTS Comparison
Compare CTSO & GUTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- GUTS
- Stock Information
- Founded
- CTSO 1997
- GUTS 2010
- Country
- CTSO United States
- GUTS United States
- Employees
- CTSO N/A
- GUTS N/A
- Industry
- CTSO Medical/Dental Instruments
- GUTS
- Sector
- CTSO Health Care
- GUTS
- Exchange
- CTSO Nasdaq
- GUTS NYSE
- Market Cap
- CTSO 52.6M
- GUTS 58.8M
- IPO Year
- CTSO N/A
- GUTS 2024
- Fundamental
- Price
- CTSO $1.18
- GUTS $2.14
- Analyst Decision
- CTSO Buy
- GUTS Buy
- Analyst Count
- CTSO 2
- GUTS 1
- Target Price
- CTSO $5.50
- GUTS $10.00
- AVG Volume (30 Days)
- CTSO 99.9K
- GUTS 369.7K
- Earning Date
- CTSO 08-12-2025
- GUTS 08-13-2025
- Dividend Yield
- CTSO N/A
- GUTS N/A
- EPS Growth
- CTSO N/A
- GUTS N/A
- EPS
- CTSO N/A
- GUTS N/A
- Revenue
- CTSO $35,332,238.00
- GUTS $60,000.00
- Revenue This Year
- CTSO $18.34
- GUTS N/A
- Revenue Next Year
- CTSO $19.82
- GUTS N/A
- P/E Ratio
- CTSO N/A
- GUTS N/A
- Revenue Growth
- CTSO 15.37
- GUTS N/A
- 52 Week Low
- CTSO $0.70
- GUTS $0.87
- 52 Week High
- CTSO $1.61
- GUTS $5.50
- Technical
- Relative Strength Index (RSI)
- CTSO 67.21
- GUTS 54.96
- Support Level
- CTSO $1.03
- GUTS $1.88
- Resistance Level
- CTSO $1.29
- GUTS $2.11
- Average True Range (ATR)
- CTSO 0.09
- GUTS 0.24
- MACD
- CTSO 0.02
- GUTS -0.03
- Stochastic Oscillator
- CTSO 75.45
- GUTS 24.58
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About GUTS FRACTYL HEALTH INC
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.